Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07776275
RecruitingNCT07776275ClinicalTrials.gov record

Physical Profile of Cervicogenic Headache: Comparison With Neck Pain and Healthy Controls

Cervicogenic Headache · Chronic Neck Pain

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Observational
Phase
Not applicable / not listed
Age range
25 years - 60 years
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
135 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The goal of this observational study is to compare physical findings across three adult groups. Cervicogenic headache (CGH) is a headache linked to a problem in the neck. Neck pain may affect posture, muscle function, grip strength, and sensitivity to pressure. Researchers do not know whether CGH has a distinct pattern of these findings.

The main questions are:

  • Do posture, grip strength, muscle stiffness, elasticity, and pressure sensitivity differ among the groups?
  • Are any differences more closely associated with CGH than with neck pain?

Researchers will compare adults ages 25 through 60. One group will include people with CGH lasting at least three months. Another group will include people with neck pain lasting at least six months. People in the neck pain group will have no headaches. Healthy participants will have no neck pain or headaches.

Researchers will not provide treatment or change participants' usual care. Each participant will complete one study visit lasting about 15 minutes. Participants will:

  • Answer short questions about their health and pain
  • Stand while researchers measure their head and neck posture
  • Squeeze a device that measures grip strength
  • Complete brief tests of neck muscle stiffness and elasticity
  • Tell researchers when applied pressure first becomes painful

Researchers will compare results across the three groups. The findings may guide future CGH assessment and treatment research.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

  • Inclusion Criteria:
  • Aged 25 to 60 years
  • Able to provide written informed consent
  • Meeting the criteria for one of the following groups:
  • Cervicogenic headache: physician diagnosis according to the International Classification of Headache Disorders, 3rd edition, with symptoms lasting at least 3 months
  • Chronic nonspecific neck pain: neck pain lasting at least 6 months without headache
  • Healthy control: no neck pain or headache

Exclusion Criteria:

  • Receipt of physiotherapy for headache or neck pain during the previous 6 months
  • Diagnosis of a headache disorder other than cervicogenic headache, including migraine or tension-type headache, or a diagnosis of trigeminal neuralgia
  • History of cervical spine surgery or significant cervical trauma
  • Current or previous diagnosis of a tumor or cancer
  • Serious cardiovascular, cerebrovascular, hematological, metabolic, neurological, or psychiatric disorder
  • Rheumatoid arthritis
  • Congenital cervical abnormality
  • Cervical spondylolisthesis or cervical instability
  • Active infection
  • Temporomandibular joint dysfunction
  • Dizziness or visual disturbance accompanying headache
  • Any clinical red flag suggesting serious cervical pathology
  • Pregnancy or breastfeeding
  • Upper-extremity injury, surgery, or another condition affecting handgrip strength
  • Serious musculoskeletal disorder affecting cervical posture or muscle measurements
  • Inability to complete the questionnaire-based or instrument-based assessments

Study population

The study population consists of adults aged 25-60 years recruited at the study site in Istanbul, Türkiye. Participants are classified into three groups according to predefined clinical criteria. The cervicogenic headache group includes individuals diagnosed by a physician according to the International Classification of Headache Disorders, 3rd edition. The chronic nonspecific neck pain group includes individuals with neck pain lasting at least 6 months and no headache. The healthy control group includes individuals without neck pain or headache. Participants receive no study intervention and complete one questionnaire-based and instrument-based assessment session.

Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not reported
Masking
Not reported
Cervicogenic Headache Group

Adults aged 25-60 years with cervicogenic headache diagnosed by a physician according to the International Classification of Headache Disorders, 3rd edition (ICHD-3), and symptoms lasting at least 3 months. Participants undergo one questionnaire-based and instrument-based assessment session. No intervention is assigned.

Chronic Nonspescific Neck Pain Group

Adults aged 25-60 years with chronic nonspecific neck pain lasting at least 6 months and no headache. Participants undergo one questionnaire-based and instrument-based assessment session. No intervention is assigned.

Healthy Control Group

Adults aged 25-60 years with no neck pain or headaches. Participants undergo one questionnaire-based and instrument-based assessment session. No intervention is assigned.

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Bilateral Upper Trapezius Muscle Stiffness

Time frame: During the single assessment session at enrollment

Upper trapezius muscle stiffness will be assessed bilaterally using the MyotonPRO device. Three consecutive measurements will be obtained at the midpoint between the C7 spinous process and the lateral border of the acromion. The mean of the three measurements will be used. Stiffness will be expressed in newtons per meter (N/m), with higher values indicating greater stiffness.

Bilateral Upper Trapezius Logarithmic Decrement

Time frame: During the single assessment session at enrollment

Upper trapezius logarithmic decrement will be assessed bilaterally using the MyotonPRO device at the same standardized measurement site. Three consecutive measurements will be obtained on each side, and their mean will be used. Logarithmic decrement is a dimensionless inverse indicator of tissue elasticity, with lower values indicating greater elasticity.

Secondary measures

Bilateral Handgrip Strength

Time frame: During the single assessment session at enrollment

Bilateral handgrip strength will be measured using a Jamar Hydraulic Hand Dynamometer set to the second handle position. Participants will perform three maximal contractions with each hand in a standardized seated position. The highest value for each hand will be recorded in kilograms, with higher values indicating greater handgrip strength.

Bilateral Upper Trapezius Pressure Pain Threshold

Time frame: During the single assessment session at enrollment

Pressure pain threshold will be measured bilaterally over the upper trapezius using a handheld pressure algometer with a 1-cm² probe. The measurement site will be the midpoint between the C7 spinous process and the lateral border of the acromion. Pressure will gradually increase until the participant first reports pain. Values will be recorded in kg/cm², with higher values indicating a higher pressure pain threshold.

Bilateral Suboccipital Pressure Pain Threshold

Time frame: During the single assessment session at enrollment

Pressure pain threshold will be measured bilaterally over the suboccipital region using a handheld pressure algometer with a 1-cm² probe. The measurement site will be located 2 cm lateral to the C2 spinous process. Pressure will gradually increase until the participant first reports pain. Values will be recorded in kg/cm², with higher values indicating a higher pressure pain threshold.

Tragus-to-Wall Distance

Time frame: During the single assessment session at enrollment

Tragus-to-wall distance will be measured in millimeters using a tape measure. Participants will stand with their heels, sacrum, and thoracic spine resting comfortably against a wall while maintaining a natural head position. The distance between the wall and the tragus will be recorded. Greater distances indicate greater forward positioning of the head.

Craniovertebral Angle

Time frame: During the single assessment session at enrollment

The craniovertebral angle will be measured in degrees using a universal goniometer. The fulcrum will be positioned over the lateral projection of the C7 spinous process. The stationary arm will remain parallel to the floor, and the movable arm will point toward the tragus. Three measurements will be obtained, and their mean will be used. Smaller angles indicate greater forward head posture.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Medipol Sefaköy Üniversite HastanesiIstanbul, Sefaköy, Turkey (Türkiye)Recruiting

Study team and timeline

Lead sponsor
Istanbul Medipol University Hospital
Study start
Apr 21, 2026 Actual
Primary completion
Nov 8, 2026 Actual
Study completion
Nov 30, 2026 Estimated
First posted
Aug 20, 2026 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

Fatih Bali, PhD.CONTACTfatihbali@hotmail.com+905323937689
Official study title

A Multidimensional Physical Profile of Cervicogenic Headache: A Cross-Sectional Comparison With Nonspecific Neck Pain and Healthy Controls

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026